MD Magazine (1/11, Lutz) reported, “Psychiatric disorders and substance use disorders might reduce the efficacy of antiepileptic” medicines “among patients with epilepsy,” researches concluded after analyzing “data searching for treatment success and comorbid psychiatric diseases, including anxiety, schizophrenia, depression, and bipolar disorder, or substance use disorder including the use of substances, opioids, or cannabis.” The findings of the “more than 175,000”-patient study were presented American Epilepsy Society’s recent annual meeting.
Related Links:
— “Substance Use Disorder Reduces Antiepileptic Medication Success, “Rachel Lutz, MD Magazine, January 11, 2019